Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1β gene in the Iranian population

Inflammation

Volumn 35, Issue 3, 2012, Pages 900-904

  Derakhshan, Reza ^a   Arababadi, Mohammad Kazemi ^a   Ahmadi, Zahra ^a   Karimabad, Mojgan Noroozi ^a   Salehabadi, Vajihe Akbarpour ^a   Abedinzadeh, Mehdi ^a   Khorramdelazad, Hossein ^a   Balaei, Parisa ^a   Kennedy, Derek ^b   Hassanshahi, Gholamhossein ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Polymorphism; SDF 1; Type 2 diabetes

Indexed keywords

DNA; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1BETA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; IRANIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STROMAL CELL DERIVED FACTOR 1BETA GENE;

ADULT; CHEMOKINE CXCL12; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENOTYPE; HUMANS; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863807894     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9391-8     Document Type: Article

References (19)

1. Steyn, N.P., E.V. Lambert, and H. Tabana. 2009. Conference on "Multidisciplinary approaches to nutritional problems". Symposium on "Diabetes and health". Nutrition interventions for the prevention of type 2 diabetes. Proceedings of the Nutrition Society 68: 55-70.
2. Arababadi, M.K., Mirzaei, M., Sajadi, S.M.A., Hassanshahi, G., Ahmadababdi, B.N., Salehabadi, V.A., Derakhshan, R., Kennedy, D. 2011. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: a study of patients from the South-East region of Iran. Inflammation (in press).
3. Olivares-Reyes, J.A., A. Arellano-Plancarte, and J.R. Castillo-Hernandez. 2009. Angiotensin II and the development of insulin resistance: implications for diabetes. Molecular and Cellular Endocrinology 302: 128-139.
4. Cruz, M., C. Maldonado-Bernal, R. Mondragon-Gonzalez, R. Sanchez-Barrera, N.H. Wacher, G. Carvajal-Sandoval, and J. Kumate. 2008. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. Journal of Endocrinological Investigation 31: 694-699.
5. Giulietti, A., E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu. 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Research and Clinical Practice 77: 47-57. (Pubitemid 46590467)
6. Nathanson, D., and T. Nystrom. 2009. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Molecular and Cellular Endocrinology 297: 112-126.
7. Tsiavou, A., D. Degiannis, E. Hatziagelaki, K. Koniavitou, and S.A. Raptis. 2004. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. Journal of Interferon & Cytokine Research 24: 381-387. (Pubitemid 38998786)
8. Skopinski, P., E. Rogala, B. Duda-Krol, A. Lipinska, E. Sommer, J. Chorostowska-Wynimko, J. Szaflik, I. Partyka, and E. Skopinska-Rozewska. 2005. Increased interleukin-18 content and angiogenic activity of sera from diabetic (type 2) patients with background retinopathy. Journal of Diabetes and its Complications 19: 335-338. (Pubitemid 41563016)
9. Pickup, J.C., G.D. Chusney, S.M. Thomas, and D. Burt. 2000. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sciences 67: 291-300. (Pubitemid 30413937)
10. Arababadi, M.K., R. Nosratabadi, G. Hassanshahi, N. Yaghini, V. Pooladvand, A. Shamsizadeh, H. Hakimi, and R. Derakhshan. 2009. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Diabetes Research and Clinical Practice 87: 33-37.
11. Hassanshahi, G., S.S. Patel, A.A. Jafarzadeh, and A.J. Dickson. 2007. Expression of CXC chemokine IP-10/Mob-1 by primary hepatocytes following heat shock. Saudi Medical Journal 28: 514-518. (Pubitemid 47046027)
12. Hassanshahi, G., A. Jafarzadeh, and D.A. James. 2008. Expression of stromal derived factor alpha (SDF-1 alpha) by primary hepatocytes following isolation and heat shock stimulation. Iranian Journal of Allergy, Asthma, and Immunology 7: 61-68.
13. Daryani, A., A.Z. Hosseini, and A. Dalimi. 2003. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Veterinary Parasitology 113: 123-134. (Pubitemid 36412129)
14. Kimura, R., T. Nishioka, and T. Ishida. 2003. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes and Immunity 4: 356-361. (Pubitemid 38961143)
15. Hassanshahi, G., M.K. Arababadi, H. Khoramdelazad, N. Yaghini, and E.R. Zarandi. 2010. Assessment of CXCL12 (SDF-1alpha) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran. Archives of Medical Research 41: 338-342.
16. Alfadda, A.A., and M.A. Alzoghaibi. 2008. Circulatory neutrophil chemokines in statin-treated diabetic patients. Saudi Medical Journal 29: 584-588.
17. Yuen, M.F., C.K. Lee, D.K. Wong, J. Fung, I. Hung, A. Hsu, D.Y. But, T.K. Cheung, P. Chan, J.C. Yuen, F.K. Fung, W.K. Seto, C.K. Lin, and C.L. Lai. 2011. Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut 59: 1389-1393.
18. Ebrahimi, H., M. Soleimani, M. Kazemi Arababadi, N. Ahmadbeigi, G. Hassanshahi, A. Farjadfar, and D. Kennedy. 2010. An in vitro assay to evaluate the immunomodulatory effects of unrestricted somatic stem cells. Iranian Journal of Immunology 7: 30-38.
19. Sayyed, S.G., H. Hagele, O.P. Kulkarni, K. Endlich, S. Segerer, D. Eulberg, S. Klussmann, and H.J. Anders. 2009. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 52: 2445-2454.